Inhibition of voltage-gated K+ channels in dendritic cells by rapamycin

American Journal of Physiology - Cell Physiology

Volumn 299, Issue 6, 2010, Pages

  Tyan, Leonid ^a   Sopjani, Mentor ^a   Dërmaku Sopjani, Miribane ^a   Schmid, Evi ^a   Yang, Wenting ^a   Xuan, Nguyen Thi ^a   Shumilina, Ekaterina ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cell membrane potential; Immunosuppression; Kv1.3; Kv1.5; Macrophages; Mammalian target of rapamycin

Indexed keywords

ION CHANNEL; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL FUNCTION; DENDRITIC CELL; DRUG EFFECT; FEMALE; MALE; MEMBRANE CURRENT; MOUSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; XENOPUS;

ANIMALS; BONE MARROW; DENDRITIC CELLS; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MALE; MEMBRANE POTENTIALS; MICE; POTASSIUM CHANNELS, VOLTAGE-GATED; SIROLIMUS; TOR SERINE-THREONINE KINASES;

MAMMALIA; MURINAE;

EID: 78649643404     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00367.2010     Document Type: Article

References (67)

1. Ahn HS, Kim SE, Choi BH, Choi JS, Kim MJ, Rhie DJ, Yoon SH, Jo YH, Kim MS, Sung KW, Kwon OJ, Hahn SJ. Calcineurin-independent inhibition of KV1.3 by FK-506 (tacrolimus): a novel pharmacological property. Am J Physiol Cell Physiol 292: C1714-C1722, 2007.
2. Araki K, Turner AP, Shaffer VO, Gangappa S, Keller SA, Bachmann MF, Larsen CP, Ahmed R. mTOR regulates memory CD8 T-cell differentiation. Nature 460: 108-112, 2009.
3. Ballou LM, Lin RZ. Rapamycin and mTOR kinase inhibitors. J Chem Biol 1: 27-36, 2008.
4. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 392: 245-252, 1998.
5. Barry PH, Lynch JW. Liquid junction potentials and small cell effects in patch-clamp analysis. J Membr Biol 121: 101-117, 1991.
6. Boehmer C, Laufer J, Jeyaraj S, Klaus F, Lindner R, Lang F, Palmada M. Modulation of the voltage-gated potassium channel Kv1.5 by the SGK1 protein kinase involves inhibition of channel ubiquitination. Cell Physiol Biochem 22: 591-600, 2008.
7. Boehmer C, Palmada M, Klaus F, Jeyaraj S, Lindner R, Laufer J, Daniel H, Lang F. The peptide transporter PEPT2 is targeted by the protein kinase SGK1 and the scaffold protein NHERF2. Cell Physiol Biochem 22: 705-714, 2008.
8. Bowlby MR, Fadool DA, Holmes TC, Levitan IB. Modulation of the Kv1.3 potassium channel by receptor tyrosine kinases. J Gen Physiol 110: 601-610, 1997.
9. Carmona EM, Vassallo R, Vuk-Pavlovic Z, Standing JE, Kottom TJ, Limper AH. Pneumocystis cell wall beta-glucans induce dendritic cell costimulatory molecule expression and inflammatory activation through a Fas-Fas ligand mechanism. J Immunol 177: 459-467, 2006.
10. Cayabyab FS, Khanna R, Jones OT, Schlichter LC. Suppression of the rat microglia Kv1.3 current by src-family tyrosine kinases and oxygen/glucose deprivation. Eur J Neurosci 12: 1949-1960, 2000.
11. Chapman AB. Autosomal dominant polycystic kidney disease: time for a change? J Am Soc Nephrol 18: 1399-1407, 2007.
12. Chung I, Schlichter LC. Regulation of native Kv1.3 channels by cAMP-dependent protein phosphorylation. Am J Physiol Cell Physiol 273: C622-C633, 1997. (Pubitemid 27396156)
13. Colley BS, Biju KC, Visegrady A, Campbell S, Fadool DA. Neurotrophin B receptor kinase increases Kv subfamily member 1.3 (Kv13) ion channel half-life and surface expression. Neuroscience 144: 531-546, 2007.
14. Cook KK, Fadool DA. Two adaptor proteins differentially modulate the phosphorylation and biophysics of Kv1.3 ion channel by SRC kinase. J Biol Chem 277: 13268-13280, 2002.
15. Delgoffe GM, Powell JD. mTOR: taking cues from the immune micro-environment. Immunology 127: 459-465, 2009.
16. Dubsky P, Ueno H, Piqueras B, Connolly J, Banchereau J, Palucka AK. Human dendritic cell subsets for vaccination. J Clin Immunol 25: 551-572, 2005.
17. Dunlop EA, Tee AR. Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms. Cell Signal 21: 827-835, 2009.
18. Espuelas S, Roth A, Thumann C, Frisch B, Schuber F. Effect of synthetic lipopeptides formulated in liposomes on the maturation of human dendritic cells. Mol Immunol 42: 721-729, 2005.
19. Fischer DC, Jacoby U, Pape L, Ward CJ, Kuwertz-Broeking E, Renken C, Nizze H, Querfeld U, Rudolph B, Mueller-Wiefel DE, Bergmann C, Haffner D. Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD). Nephrol Dial Transplant 24: 1819-1827, 2009.
20. Fukao T, Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol 24: 358-363, 2003.
21. Fukao T, Tanabe M, Terauchi Y, Ota T, Matsuda S, Asano T, Kadowaki T, Takeuchi T, Koyasu S. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat Immunol 3: 875-881, 2002.
22. Fulcher JA, Hashimi ST, Levroney EL, Pang M, Gurney KB, Baum LG, Lee B. Galectin-1-matured human monocyte-derived dendritic cells have enhanced migration through extracellular matrix. J Immunol 177: 216-226, 2006.
23. Fumarola C, La Monica S, Alfieri RR, Borra E, Guidotti GG. Cell size reduction induced by inhibition of the mTOR/S6K-signaling pathway protects Jurkat cells from apoptosis. Cell Death Differ 12: 1344-1357, 2005.
24. Gamper N, Fillon S, Feng Y, Friedrich B, Lang PA, Henke G, Huber SM, Kobayashi T, Cohen P, Lang F. K(+) channel activation by all three isoforms of serum- and glucocorticoid-dependent protein kinase SGK. Pflügers Arch 445: 60-66, 2002.
25. + channels via PI3-kinase, PDK1 and SGK1. Pflügers Arch 443: 625-634, 2002.
26. Garcia-Martinez JM, Alessi DR. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 416: 375-385, 2008.
27. Goberdhan DC, Boyd CA. mTOR: dissecting regulation and mechanism of action to understand human disease. Biochem Soc Trans 37: 213-216, 2009.
28. Gulbins E, Szabo I, Baltzer K, Lang F. Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases. Proc Natl Acad Sci USA 94: 7661-7666, 1997.
29. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391: 85-100, 1981.
30. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E, Miller RA. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460: 392-395, 2009.
31. + channel Kv1.3 by the ubiquitin ligase Nedd4-2 and the serum and glucocorticoid inducible kinase SGK1. J Cell Physiol 199: 194-199, 2004.
32. Henrion U, Strutz-Seebohm N, Duszenko M, Lang F, Seebohm G. Long QT syndrome-associated mutations in the voltage sensor of I(Ks) channels. Cell Physiol Biochem 24: 11-16, 2009.
33. Hoarau C, Lagaraine C, Martin L, Velge-Roussel F, Lebranchu Y. Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J Allergy Clin Immunol 117: 696-702, 2006.
34. Hong F, Larrea MD, Doughty C, Kwiatkowski DJ, Squillace R, Slingerland JM. mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation. Mol Cell 30: 701-711, 2008.
35. Katz J, Zhang P, Martin M, Vogel SN, Michalek SM. Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVS. Infect Immun 74: 2809-2816, 2006.
36. Kempe DS, Dermaku-Sopjani M, Frohlich H, Sopjani M, Umbach A, Puchchakayala G, Capasso A, Weiss F, Stubs M, Foller M, Lang F. Rapamycin-induced phosphaturia. Nephrol Dial Transplant 25: 2938-2944, 2010.
37. Kinkade CW, Castillo-Martin M, Puzio-Kuter A, Yan J, Foster TH, Gao H, Sun Y, Ouyang X, Gerald WL, Cordon-Cardo C, Abate-Shen C. Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model. J Clin Invest 118: 3051-3064, 2008.
38. Kwak YG, Hu N, Wei J, George AL Jr, Grobaski TD, Tamkun MM, Murray KT. Protein kinase A phosphorylation alters Kvbeta1.3 subunit-mediated inactivation of the Kv15 potassium channel. J Biol Chem 274: 13928-13932, 1999.
39. Lang F, Bohmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev 86: 1151-1178, 2006.
40. + exchanger regulatory factor 2. Cell Physiol Biochem 23: 25-36, 2009.
41. Liu P, Cheng H, Roberts TM, Zhao JJ. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8: 627-644, 2009.
42. MacDonald A, Scarola J, Burke JT, Zimmerman JJ. Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus. Clin Ther 22, Suppl B: B101-B121, 2000.
43. Martelli AM, Evangelisti C, Chiarini F, Grimaldi C, Manzoli L, McCubrey JA. Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia. Expert Opin Investig Drugs 18: 1333-1349, 2009.
44. Martin DE, Hall MN. The expanding TOR signaling network. Curr Opin Cell Biol 17: 158-166, 2005.
45. Matzner N, Zemtsova IM, Nguyen TX, Duszenko M, Shumilina E, Lang F. Ion channels modulating mouse dendritic cell functions. J Immunol 181: 6803-6809, 2008.
46. Mezey E, Rennie-Tankersley L, Potter JJ. Effect of leptin on liver alcohol dehydrogenase. Biochem Biophys Res Commun 337: 1324-1329, 2005.
47. Mullen KM, Rozycka M, Rus H, Hu L, Cudrici C, Zafranskaia E, Pennington MW, Johns DC, Judge SI, Calabresi PA. Potassium channels K(v)1.3 and K(v)1.5 are expressed on blood-derived dendritic cells in the central nervous system. Ann Neurol 60: 118-127, 2006.
48. Paoletti E, Cannella G. Reducing the risk of left ventricular hypertrophy in kidney transplant recipients: the potential role of mammalian target of rapamycin. Transplant Proc 41: S3-S5, 2009.
49. Parekh AB, Penner R. Store depletion and calcium influx. Physiol Rev 77: 901-930, 1997.
50. Prlic M, Bevan MJ. Immunology: a metabolic switch to memory. Nature 460: 41-42, 2009.
51. Proud CG. Amino acids and mTOR signalling in anabolic function. Biochem Soc Trans 35: 1187-1190, 2007.
52. Schakel K, von Kietzell M, Hansel A, Ebling A, Schulze L, Haase M, Semmler C, Sarfati M, Barclay AN, Randolph GJ, Meurer M, Rieber EP. Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes. Immunity 24: 767-777, 2006.
53. + channels in brain macrophages. Pflügers Arch 447: 312-315, 2003.
54. Scott KL, Kabbarah O, Liang MC, Ivanova E, Anagnostou V, Wu J, Dhakal S, Wu M, Chen S, Feinberg T, Huang J, Saci A, Widlund HR, Fisher DE, Xiao Y, Rimm DL, Protopopov A, Wong KK, Chin L. GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature 459: 1085-1090, 2009.
55. Shumilina E, Lampert A, Lupescu A, Myssina S, Strutz-Seebohm N, Henke G, Grahammer F, Wulff P, Kuhl D, Lang F. Deranged Kv channel regulation in fibroblasts from mice lacking the serum and glucocorticoid inducible kinase SGK1. J Cell Physiol 204: 87-98, 2005.
56. Shumilina E, Zahir N, Xuan NT, Lang F. Phosphoinositide 3-kinase dependent regulation of Kv channels in dendritic cells. Cell Physiol Biochem 20: 801-808, 2007.
57. Sopjani M, Alesutan I, Dermaku-Sopjani M, Fraser S, Kemp BE, Foller M, Lang F. Down-regulation of Na-coupled glutamate transporter EAAT3 and EAAT4 by AMP-activated protein kinase. J Neurochem 113: 1426-1435, 2010.
58. + channel in T lymphocytes upon Fas stimulation. J Biol Chem 271: 20465-20469, 1996.
59. 2+ entry by IGF-1 in human embryonic kidney cells. Pflügers Arch 445: 74-79, 2002.
60. Ueno M, Carvalheira JB, Tambascia RC, Bezerra RM, Amaral ME, Carneiro EM, Folli F, Franchini KG, Saad MJ. Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway. Diabetologia 48: 506-518, 2005.
61. Ullrich S, Berchtold S, Ranta F, Seebohm G, Henke G, Lupescu A, Mack AF, Chao CM, Su J, Nitschke R, Alexander D, Friedrich B, Wulff P, Kuhl D, Lang F. Serum- and glucocorticoid-inducible kinase 1 (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion. Diabetes 54: 1090-1099, 2005.
62. + channels Kir2.3. Cell Physiol Biochem 21: 347-356, 2008.
63. Wagner CA, Friedrich B, Setiawan I, Lang F, Broer S. The use of Xenopus laevis oocytes for the functional characterization of heterologously expressed membrane proteins. Cell Physiol Biochem 10: 1-12, 2000.
64. Wang X, Sun SY. Enhancing mTOR-targeted cancer therapy. Expert Opin Ther Targets 13: 1193-1203, 2009.
65. Wärntges S, Friedrich B, Henke G, Duranton C, Lang PA, Waldegger S, Meyermann R, Kuhl D, Speckmann EJ, Obermuller N, Witzgall R, Mack AF, Wagner HJ, Wagner A, Broer S, Lang F. Cerebral localization and regulation of the cell volume-sensitive serum- and glucocorticoid-dependent kinase SGK1. Pflügers Arch 443: 617-624, 2002.
66. +-dependent functions in peptidoglycan-stimulated mouse dendritic cells. Cell Physiol Biochem 24: 167-176, 2009.
67. Yan L, Mieulet V, Lamb RF. mTORC2 is the hydrophobic motif kinase for SGK1. Biochem J 416: e19-e21, 2008.